We provide artificial intelligence services to all players in the healthcare arena, including academic institutions, hospitals, pharmaceutical companies and biotech companies. These services include data processing, encoding and access to advanced deep learning solutions for:

Identification of pathophysiological processes that drive certain diseases.
Discovery and classification of new chemical entites.
Prediction of specific target-binding affinities or drug-like properties.
Identification of chemical structures associated to certain toxic effects.
Prediction of unexpected human toxicity.
Selection of drug candidates for clinical trials.
Early identification of subpopulations at a higher risk of certain diseases.
Matching drugs no longer used with new clinical indications.
Prediction of “super-response” to specific drugs.
Monitoring quality of life and lifestyle changes.

Need more information?